Adalimumab in the therapy of uveitis in childhood.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17322463.
- Also identified by PMC identifier 1857669.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
“Adalimumab is more effective” …?
Medical subject headings
- Anti-Inflammatory Agents
- Antibodies, Monoclonal
- Tumor Necrosis Factor-alpha
- Uveitis